Otsuka Icu Medcl Company Profile
What is the competitive landscape for OTSUKA ICU MEDCL
OTSUKA ICU MEDCL has forty-six approved drugs.
Summary for Otsuka Icu Medcl
| US Patents: | 0 |
| Tradenames: | 68 |
| Ingredients: | 21 |
| NDAs: | 46 |
Drugs and US Patents for Otsuka Icu Medcl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Icu Medcl | POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate | INJECTABLE;INJECTION | 019685-003 | Oct 17, 1988 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Otsuka Icu Medcl | POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | potassium chloride; sodium chloride | INJECTABLE;INJECTION | 078446-001 | Sep 10, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Otsuka Icu Medcl | MANNITOL 10% IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 019603-002 | Jan 8, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
